News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celek Pharmaceuticals, LLC to Present Recent Progress on its Anticancer Drug Candidate, CEL-031, at National Cancer Institute Investor Forum


4/18/2012 10:16:30 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--Celek Pharmaceuticals announced that it will present an update on its anticancer drug development programs today at the National Cancer Institute (NCI)’s 2012 Investor Forum in Santa Clara, CA. The NCI selected Celek as one of 18 companies from more than 100 applicants to present at this conference. Only companies funded under the NCI’s Small Business Innovation Research (SBIR) program were eligible to apply.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES